Quick search:
Content Ideas
| Result | Content Idea | Research |
|---|---|---|
| Result | Content Idea | Research |
| 1 | Radiation Therapy in SCLC -- ASCO Endorses ASTRO Guideline |
|
| 2 | Richard Schilsky Bids Adieu to ASCO |
|
| 3 | ACCC and ASCO Collaborative Targets Disparities in Cancer Clinical Trials |
|
| 4 | Insights from the ASCO Genitourinary Cancers Symposium |
|
| 5 | ASCO Publishes 2021 Report on Progress Against Cancer |
|
| 6 | ASCO GU: Merck, Eisai turn up the heat in kidney cancer with Keytruda-Lenvima survival data |
|
| 7 | Katherine Virgo, PhD, on Updated ASCO Prostate Cancer Guidelines |
|
| 8 | ASCO GU 2021: Use of Genomics to Guide Treatment Decisions in Post-Prostatectomy Patients |
|
| 9 | Noxopharm Shares Major Cancer Survival Benefit at ASCO Global Conference |
|
| 10 | Asco-GU – confirmatory Padcev trial throws a curveball |
|
| 11 | ASCO GU: With 2-year data, the jury's still out on the kidney cancer race between Opdivo-Cabometyx and Keytruda-Inlyta |
|
| 12 | ASCO White Paper Explains Paralleling Switchgear for Multi-Generator Backup Systems |
|
| 13 | ImmunityBio Announces ASCO Genitourinary Cancer Symposium Presentation of Phase 2/3 Trial for BCG Unresponsive Non-Muscle Invasive Bladder Cancer CIS with 71% Complete Response Rate |
|
| 14 | Former CMO and Execute VP of ASCO on Molecular Profiling in GI Cancer and Health Inequity |
|
| 15 | ASCO GU 2021: Active Surveillance in 2021 and Beyond |
|
| 16 | Schilsky and Gralow Share Advice for ASCO Leadership and Therapeutic Equity in Cancer |
|
| 17 | ASCO GU 2021: Safety of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer From Extended F... |
|
| 18 | ASCO GU 2021: Germline Alterations in Cancer Susceptibility Genes in Women with High-Risk Bladder Cancer: I... |
|
| 19 | ASCO GU 2021: Best of Journals: Urothelial Cancer |
|
| 20 | Licensing Fee-asco: Cannabis Advocates Question How DHS Is Handling Dispensary Licenses |
|
| 21 | ASCO GU 2021: Nivolumab + Cabozantinib Versus Sunitinib for Advanced Renal Cell Carcinoma (aRCC): Outcomes ... |
|
| 22 | ASCO Power Technologies to Host Ask The Experts – Data Centers Q & A |
|
| 23 | ASCO GU 2021: Updated Outcomes of POUT: A Phase III Randomized Trial of Peri-Operative Chemotherapy Versus ... |
|
| 24 | ASCO GU 2021: Gene Expression Profiling to Identify Metabolic Gene Signature Predictive of Recurrence After... |
|
| 25 | ASCO GU 2021: Outcomes For Patients In the Pembrolizumab+Axitinib Arm With Advanced Renal Cell Carcinoma Wh... |
|
| 26 | ASCO's Early Breast Cancer Guidelines Updated to Include T-DM1 |
|
| 27 | ASCO GU 2021: Clinical Outcomes of Patients With mCRPC Receiving Radium-223 Early Versus Late in the Treatm... |
|
| 28 | ASCO GU 2021: Analysis of the Effect of Crossover from Placebo to Darolutamide on Overall Survival Benefit ... |
|
| 29 | ASCO GU 2021: Beyond the Basics: Harnessing the Immune System to Fight Prostate Cancer |
|
| 30 | ASCO GU 2021: TIVO-3: Tivozanib in Patients with Advanced Renal Cell Carcinoma Who Have Progressed After Tr... |
|
| 31 | ASCO GU 2021: First Results from the Phase 3 CheckMate 274 Trial of Adjuvant Nivolumab vs Placebo in Patien... |
|
| 32 | ASCO GU 2021: Invited Discussion: Testicular Seminoma |
|
| 33 | ASCO GU 2021: Final Results from ACIS, a Randomized, Placebo-Controlled Double-Blind Phase 3 Study of Apalu... |
|
| 34 | ASCO GU 2021: Primary Results of EV-301: A Phase III Trial of Enfortumab Vedotin Versus Chemotherapy in Pat... |
|
| 35 | ASCO GU 2021: SURE: An Open Label, Sequential-Arm, Phase II Study of Neoadjuvant Sacituzumab Govitecan, and... |
|
| 36 | ASCO GU 2021: Overall Survival and Metastasis-Free Survival by Depth of PSA Decline in the Phase III PROSPE... |
|
| 37 | ASCO GU 2021: Alignment and Discordances in Perceptions and Experiences of Shared Decision Making Among Bla... |
|
| 38 | ASCO GU 2021: Enfortumab Vedotin in Previously Treated Urothelial Cancer |
|
| 39 | Global Solenoid Valves Market (2021-2026) with Top Growth Companies: ASCO, Kendrion, Danfoss, Parker, Bürkert – NeighborWebSJ |
|
| 40 | ASCO GU 2021: Phase IIb Trial of Oral ModraDoc006/ritonavir as a Tolerable and Effective Option in Comparis... |
|
| 41 | ASCO GU 2021: Back to Basics in Personalization: Returning to PTEN |
|
| 42 | Nisha S. Joseph, MD, on Induction/Risk-Adapted Maintenance Therapy in Myeloma |
|
| 43 | ASCO GU 2021: Phase IIB Trial of Oral ModraDoc006/r as a Tolerable and Effective Option in Comparison with ... |
|
| 44 | ASCO GU 2021: Radical Cystectomy for High-Risk Non-Muscle-Invasive Bladder Cancer: Who and Why? |
|
| 45 | ASCO GU 2021: CDKN2A Alterations as Markers of Immune Checkpoint Blockade Resistance In Urothelial Carcinoma |
|
| 46 | Bayer to Present Data that Reinforce Established Prostate Cancer Portfolio at 2021 ASCO GU Cancers Symposium |
|
| 47 | ASCO GU 2021: Atezolizumab Monotherapy vs Chemotherapy in Previously Untreated Locally Advanced or Metastat... |
|
| 48 | ASCO GU 2021: Characterization of FOXF1 as a Novel Regulator of Nodal Metastasis in Bladder Cancer |
|
| 49 | ASCO GU 2021: Association Between Tumor Mutational Burden and Immune-Related Adverse Events in Patients wit... |
|
| 50 | ASCO GU 2021: Bench to Bedside: Critical Pathways in Renal Cell Carcinoma |
|
| 51 | ASCO GU 2021: NAXIVA: A Phase II Neoadjuvant Study of Axitinib for Reducing Extent of Venous Tumor Thrombus... |
|
| 52 | ASCO GU 2021: Efficacy and Safety of Avelumab plus Axitinib (A + Ax) Versus Sunitinib (S) in Elderly Patien... |
|
| 53 | ASCO GU 2021: Genomic Landscape of Advanced Prostate Cancer In Racial Minority Populations: Real-World Expe... |
|
| 54 | ASCO GU 2021: TROPiCS-04: Study of Sacituzumab Govitecan in Metastatic Or Locally Advanced Unresectable Uro... |
|
| 55 | ASCO GU 2021: PI3K/AKT Pathway Biomarkers Analysis from the Phase III IPATential150 Trial of Ipatasertib pl... |
|
| 56 | Exelixis Announces Positive Findings at ASCO GU for CABOMETYX® (cabozantinib) in Patients with Brain Metastases from Renal Cell Carcinoma |
|
| 57 | ASCO GU 2021: Exploratory Gene-By-Gene Analysis Of Olaparib In Patients With Metastatic Castration-Resistan... |
|
| 58 | ASCO GU 2021: Safety and Efficacy Of Perioperative Cisplatin/Gemcitabine And Durvalumab For Operable Muscle... |
|
| 59 | Directional Valve Market Research & Clinical Advancements by 2028 | ASCO , Kendrion , Danfoss , Parker , Bürkert – Breakout Live |
|
| 60 | ASCO GU 2021: New therapeutic option for early metastatic testicular seminoma |
|
| 61 | ASCO GU 2021: Rucaparib plus Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer:... |
|
| 62 | Infinity Pharmaceuticals Announces Conference Call for the ASCO Genitourinary Cancers Symposium to Discuss Clinical Data from MARIO-275 Phase 2 Study |
|
| 63 | Solenoid Valves Market Size 2021 | Top Key Vendors – ASCO, CKD, Parker, Kendrion, Norgren – Breakout Live |
|
| 64 | ASCO GU 2021: A Prospective Phase II/III Study of PSMA-Targeted 18F-DCFPyL-PET/CT in Patients with Prostate... |
|
| 65 | Enrico Santus, PhD, on Analyzing Prostate Pathology Reports |
|
| 66 | ASCO GU 2021: Axitinib offers hope for improving renal cell cancer surgical outcomes |
|
| 67 | ASCO GU 2021: Genomic Analysis of Circulating Tumor DNA in Patients with Advanced Prostate Cancer to Identi... |
|
| 68 | Blue Earth Diagnostics Highlights Presentations on Axumin® (Fluciclovine F 18) at Upcoming 2021 ASCO Genitourinary Cancers Symposium (ASCO GU) |
|
| 69 | ASCO GU 2021: Androgen Deprivation Therapy and Risk of SARS-CoV-2 Infection in Men with Prostate Cancer: A ... |
|
| 70 | ASCO GU 2021: Safety and Efficacy of Nivolumab in Older Patients with Renal Cell Carcinoma: Results of a Su... |
|
| 71 | Nancy Lin, MD, on Breast Cancer With Brain Metastasis |
|
| 72 | ASCO GU 2021: Superior clinical outcomes and quality of life with nivolumab plus cabozantinib in renal cell cancer |
|
| 73 | ASCO GU 2021: Cost-Effectiveness Analysis of Pembrolizumab for BCG-Unresponsive Carcinoma in Situ of the Bl... |
|
| 74 | ASCO GU 2021: Optimal Therapy for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer in the Non-cystectomy... |
|
| 75 | ASCO Power Technologies Webinar Offers Perspectives on Telecommunication Power Trends |
|
| 76 | ASCO GU 2021: Avelumab First-Line Maintenance plus Best Supportive Care (BSC) Versus BSC Alone for Advanced... |
|
| 77 | ASCO GU 2021: Prospective Randomized Trial of Gene Expression Classifier Utility Following Radical Prostate... |
|
| 78 | ASCO GU 2021: Therapy-Relevant Gene Signatures In The High Risk Localized Renal Cell Carcinoma Setting: Tra... |
|
| 79 | Steam Solenoid Valve Market 2021 Incredible Possibilities by World 2026 | ASCO, Kendrion, Danfoss – KSU | The Sentinel Newspaper |
|
| 80 | Solenoid Valves Market Size & Revenue Analysis | ASCO Valve Inc. , Christian Bürkert GmbH & Co. KG , Curtiss-Wright Corporation , Danfoss A/S |
|
| 81 | Electromagnetic Valves Market Size 2021 | Industry Growth Analysis by Key Players – ASCO, CKD, Parker, Kendrion, Norgren |
|
| 82 | Bon Secours helps to address racial & ethnic disparities in healthcare |
|
| 83 | Trending News 2021: Explosion Proof Solenoid Valves Market Research Region Wise Analysis of Top Players In Market By Its Types And Application | ASCO, Parker, Kendrion, Festo |
|
| 84 | CO2 Production Plants Market 2020 SWOT Analysis and Key Business Strategies by Leading Players – Hitachi, ASCO CARBON DIOXIDE, Universal Industrial Gases – KSU | The Sentinel Newspaper |
|
| 85 | Oncology Peer Review On-The-Go: 1-on-1 With Richard L. Schilsky, MD, on Molecular Profiling in GI Cancers |
|
| 86 | Global Filter Regulator Lubricator Market SWOT Analysis, Key Indicators, Forecast 2027 : Asco Valve(Emerson), SMC, Omega Engineering, Festo, Parker-Hannifin, Ingersoll-Rand – KSU | The Sentinel Newspaper |
|
| 87 | Manifold Solenoid Valves Market 2021 : ASCO, Kendrion, Danfoss, Parker – The Bisouv Network |
|
| 88 | GIASCO 2021 Research Recap |
|
| 89 | Global Sleeve Valves Market Trend Analysis 2020 | ASCO, Induchem Components, Vulcax, ROSS CONTROLS, Nencini, Scruggs – SoccerNurds |
|
| 90 | Emerson's Solenoid Valves Enable More Compact Machine Designs |
|
| 91 | Steam Solenoid Valve market : leading key players involved: ASCO, Kendrion, Danfoss – FLA News |
|
| 92 | Air Operated Valves Market Research Report 2021: SMC, Emerson (ASCO), High Pressure Equipment – The Bisouv Network |
|
| 93 | Sleeve Valves Market 2021 Is Rapidly Increasing Worldwide in Near Future | Top Companies Analysis- ASCO, Vulcax, Scruggs, ROSS CONTROLS, Nencini, etc. – The Bisouv Network |
|
| 94 | Automotive Metering Valves Market In-Depth Analysis including key players Graco, ASCO Valve, Mopar – NeighborWebSJ |
|
| 95 | Directional Valve Market 2021 Is Rapidly Increasing Worldwide in Near Future | Top Companies Analysis- ASCO, Kendrion, Danfoss, Parker, Bürkert, etc. – KSU | The Sentinel Newspaper |
|
| 96 | A New Standard of Care in Treatment of Advanced Urothelial Carcinoma from JAVELIN Bladder 100 |
|
| 97 | Steam Solenoid Valve Market- increasing demand with Industry Professionals: ASCO, Kendrion, Danfoss and Others – South Florida Theater Review |
|
| 98 | Global Speed Control Valve Market 2021 By Key Players Are ASCO, Kendrion, Danfoss – NeighborWebSJ |
|
| 99 | Solenoid Valves Market | Company Challenges And Driving – Parker, ASCO, Kendrion, Danfoss – South Florida Theater Review |
|
| 100 | Oil and Gas Logistics Market SWOT Analysis including key players ASCO (Scotland), CEVA Logistics (Switzerland), CH Robinson (United States) |
|